JP Morgan Chase’s Insmed INSM Stock Holding History

JP Morgan Chase’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.1M	Buy	105,000 +10,800	+11%	+$1.66M	﹤0.01%	2270
2025 Q4	$16.4M	Buy	94,200 +45,400	+93%	+$8.28M	﹤0.01%	2235
2025 Q3	$7.03M	Buy	+48,800	New	+$5.98M	﹤0.01%	3054
2025 Q1	–	Sell	-40,600	Closed	-$2.8M	–	7516
2024 Q4	$2.8M	Buy	40,600 +3,800	+10%	+$274K	﹤0.01%	3891
2024 Q3	$2.69M	Sell	36,800 -145,800	-80%	-$10.8M	﹤0.01%	3740
2024 Q2	$12.2M	Buy	182,600 +160,200	+715%	+$6.21M	﹤0.01%	2275
2024 Q1	$608K	Buy	+22,400	New	+$627K	﹤0.01%	4669
2022 Q4	–	Sell	-40,100	Closed	-$864K	–	6767
2022 Q3	$864K	Buy	+40,100	New	+$961K	﹤0.01%	4111
2022 Q1	–	Sell	-29,800	Closed	-$812K	–	6796
2021 Q4	$812K	Buy	+29,800	New	+$852K	﹤0.01%	4532
2019 Q1	–	Sell	-27,000	Closed	-$354K	–	5904
2018 Q4	$354K	Buy	+27,000	New	+$431K	﹤0.01%	4313
2018 Q2	–	Sell	-40,000	Closed	-$901K	–	5605
2018 Q1	$901K	Buy	+40,000	New	+$1.05M	﹤0.01%	3728
2017 Q4	–	Sell	-70,000	Closed	-$2.14M	–	5496
2017 Q3	$2.14M	Buy	+70,000	New	+$1.33M	﹤0.01%	3111

Other funds holding INSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase's INSM Position: Q1 2026 in Review

JP Morgan Chase increased its Insmed (INSM) stake by 4.1% in Q1 2026, buying an estimated $146M and bringing the position to 24,150,499 shares worth $3.7B. The position accounts for 0.24% of the portfolio, ranked #91.

JP Morgan Chase first reported a position in INSM in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.04B in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

JP Morgan Chase held 24,150,499 shares of Insmed worth $3.7B as of Q1 2026.
JP Morgan Chase bought 950,987 Insmed shares in Q1 2026, an estimated $146M.
Insmed made up 0.24% of JP Morgan Chase's portfolio in Q1 2026, its #91 holding.
JP Morgan Chase first reported a position in Insmed in Q2 2013 and has held it in 52 quarters since.
JP Morgan Chase's Insmed position peaked at $4.04B in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.